You are currently viewing Congratulations to Salignostics On Its Selection To The 2023 TIME’s Best Inventions List!

Salistick has made it to TIME’s prestigious list of the Best Inventions of 2023!

Salistick, the revolutionary saliva-based pregnancy test, is making waves by eliminating the “ick factor” associated with traditional methods.

As Guy Krief, Salignostics’ co-founder and deputy CEO points out, “There’s a wealth of data in saliva, and we’re harnessing it to provide a better experience for expectant mothers.”

While Salignostics awaits FDA approval, the Salistick was launched in the U.K. this summer, and the response has been phenomenal, with over 20,000 units sold in the first two months.

For more information, please visit TIME’s Best Inventions of 2023 https://time.com/collection/best-inventions-2023/6326907/salistick/

 

Where can you buy the Salistick in the UK?

The test, which costs £9.99 is being sold in 400 high street stores and online. You can purchase it at Superdrug Onlinehttps://www.superdrug.com/health/conception/pregnancy-tests/salistick-the-worlds-first-saliva-pregnancy-test/p/833569?utm_source=facebook&utm_medium=organic_social&utm_campaign=June-facebook-saliva-pregnancytest

 

Salistick is also available in Israel, UAE, and South Africa.

About Salignostics

Salignostics was founded in 2016 at the Hebrew University Medical Center of Jerusalem in Ein Kerem by a group of five like-minded Ph. D.s who identified a growing need for a cost-effective user-friendly means to monitor health well-being and disease onset through non-invasive means. The founders were Prof Aaron Palmon, (president), Dean of The Hebrew University – Hadassah School of Dental Medicine, Dr Omer Deutsch (co-CEO), Dr Guy Krief (co-CEO and cBDO), Dr Raluca Cohen (CSO) and Dr Yoav Neumann (CFO). The founders all dealt with various aspects of saliva during their doctoral studies. They found that saliva-based diagnostics could match the precision of blood-based diagnostic lab tests.

Salignostics is an Israeli company that has been developing technologies that transform saliva into a reliable body-fluid sample for lateral flow immunoassays like this β-hCG Pregnancy Rapid Test. The ingenuity of this technology lies in the ability to overcome physiological obstacles found in the chemical, biological, and physical features of saliva. The Salignostics method provides a revolutionary technological platform for saliva diagnostics across a wide range of possible uses.

Pregnancy tests were the most common tests in pharmacies and the Salignostics team set out to develop a saliva-based test to detect pregnancy as accurately but not as awkwardly as the current urine–based pregnancy tests.

Salignostics, which raised $8 million in a Series A round last year, also offers a saliva-based test for SARS-CoV-2, called SaliCov.

For further information, see: Salignostics ( https://www.salignostics.com/)

 

About JLM- BioCity

News on the many life science and healthcare companies in the Jerusalem area can be seen at https://jlm-biocity.org/jlm-biocity-innovations/. Join the JLM- BioCity LinkedIn group at https://www.linkedin.com/groups/7060787 to get the news updates sent to you and to be part of the JLM- BioCity community.

JLM- BioCity is a non-profit organization focused on developing and excelling Jerusalem’s bio-community.
We invite you, researcher, professional, investor, and executive to become part of our vision, in building Jerusalem’s Biomed eco-system.

If you want your company featured in our blogs, or news releases, please contact: info AT jlm-biocity.org